RECURSION PHARMACEUTICALS, INC. - RXRX

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$1.273B

QoQ value delta ($000)

-$106.9M (-7.74%)

Implied price effect (QoQ)

-21.59%

Total shares

397,100,689

QoQ shares delta

+59,588,941 (+17.66%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 339 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
VANGUARD GROUP INC	192,997	47,187,759	0.0%
BlackRock, Inc.	132,600	43,192,306	0.0%
ARK Investment Management LLC	123,453	40,212,769	0.96%
STATE STREET CORP	87,466	28,490,638	0.0%
BAILLIE GIFFORD & CO	72,683	23,675,407	0.07%
VANGUARD PORTFOLIO MANAGEMENT LLC	69,870	22,759,100	0.0%
VANGUARD CAPITAL MANAGEMENT LLC	68,290	22,244,387	0.0%
SOFTBANK GROUP CORP.	41,864	13,636,515	0.37%
GEODE CAPITAL MANAGEMENT, LLC	37,692	12,275,084	0.0%
MIC Capital Management UK LLP	29,607	9,644,032	8.4%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	25,744	8,385,877	0.0%
NORGES BANK	23,472	5,739,064	0.0%
GOLDMAN SACHS GROUP INC	18,621	6,065,661	0.0%
Data Collective IV GP, LLC	18,239	5,941,120	32.6%
Lingotto Investment Management LLP	18,056	5,881,738	0.36%
Sumitomo Mitsui Trust Group, Inc.	16,637	5,419,221	0.01%
Amova Asset Management Americas, Inc.	16,582	5,419,221	0.23%
UBS Group AG	15,793	5,144,389	0.0%
TWO SIGMA INVESTMENTS, LP	12,483	4,066,315	0.01%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	12,351	4,023,398	0.0%
NORTHERN TRUST CORP	12,183	3,968,411	0.0%
DCVC Opportunity Fund II GP, LLC	12,130	3,951,141	87.48%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	11,693	3,808,798	0.0%
VANGUARD FIDUCIARY TRUST CO	10,790	3,514,983	0.0%
MARSHALL WACE, LLP	8,832	2,876,928	0.01%